Physician profile
Alex Nelson
NPI 1730405408
$16,581.06
in general payments reported to CMS, 2019-2025
46 companies · $1,360 in 2025
The $1,360 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,070 · 2020: $4,160 · 2021: $1,849 · 2022: $3,770 · 2023: $968 · 2024: $2,405 · 2025: $1,360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,928 · Travel and Lodging: $805.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,928.18 |
| Travel and Lodging | $804.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,303.02 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Medtronic USA, INC. | $4,110.51 | 2019-2020 | |
| Boston Scientific Corporation | $2,875.72 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept |
| Relievant Medsystems, INC. | $1,145.52 | 2021-2023 | Intracept |
| Lundbeck LLC | $307.53 | 2022-2025 | Vyepti |
| Amgen INC. | $270.20 | 2019-2022 | |
| Abbvie INC. | $262.52 | 2021-2025 | |
| Collegium Pharmaceutical, INC. | $237.11 | 2019-2025 | Xtampza, Belbuca |
| Lilly USA, LLC | $229.32 | 2020-2024 | Emgality, Reyvow, Kisunla |
| Tersera Therapeutics LLC | $222.96 | 2022-2025 | Prialt |
| Abbott Laboratories | $213.85 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $196.06 | 2019-2025 | Relistor |
| Biohaven Pharmaceuticals, INC. | $154.18 | 2021 | |
| Supernus Pharmaceuticals, INC. | $153.52 | 2019-2022 | |
| Pfizer INC. | $144.70 | 2023-2025 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alex Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.